Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals

News   Jun 11, 2012

 
Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals
 
 
 

RELATED ARTICLES

Key Cancer-Linked Proteins Thought to be ‘Undruggable’ Until Now

News

A new study published in Nature, conducted by an alliance between industry and academia involving the University of Liverpool, highlights a new approach to targeting key cancer-linked proteins, thought to be ‘undruggable’.

READ MORE

Sekisui XenoTech Appoints New COO

News

Company hires CRO & pharma veteran, Dr. Darren Warren, as new Chief Operating Officer.

READ MORE

Arsenic Trioxide Could Extend Lives of Patients with Aggressive Brain Cancer

News

Arsenic trioxide could be a powerful therapy that could extend the lives of certain glioblastoma patients by as much as three to four times the median expectation.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE